Advent International to acquire a 50.01% stake in Suven Pharmaceuticals
Advent International; the Global private equity firm said in a statement on 26th December that it is acquiring a 50.01% stake in Hyderbad’s Suven Pharmaceuticals
Read More
Advent International also plans to launch an open offer for an additional 26% stake in Suven Pharmaceuticals at Rs. 495 shares.
Read More
businessoutreach.in